A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma

NCT05607095 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Uveal Melanoma
Melanoma
Metastatic Uveal Melanoma
Metastatic Melanoma

Interventions

BIOLOGICAL: Lifileucel (LN-144/LN-145)

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]